Welcome to Crene Biotechnology!

+86-576-88205808

Product :

AP24534 Ponatinib Hydrochloride

AP24534 Ponatinib Hydrochloride 1114544-31-8
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:AP24534 Ponatinib Hydrochloride Purity:99% min
CAS NO:1114544-31-8 Solubility:DMSO : ≥ 50 mg/mL (93.89 mM)
Molecular Formula:C29H28ClF3N6O Package:Package according to customer requirements
Molecular Weight:569.02 Storage:Store at -20℃
Quality control
Remarks
Ponatinib, also known as AP24534 is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors.
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China